AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

MESOBLAST LTD

2.360

-0.150-5.98%

Volume:3.45M

Turnover:8.16M

Market Cap:3.06B

PE:-22.98

High:2.480

Open:2.480

Low:2.340

Close:2.510

52wk High:3.310

52wk Low:1.880

Shares:1.30B

Float Shares:786.49M

Volume Ratio:1.04

T/O Rate:0.44%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.103

EPS(LYR):-0.118

ROE:-18.22%

ROA:-6.16%

PB:3.82

PE(LYR):-20.00

Loading ...

Overview Company News Filings

Founder Led Stocks For Investors Watching Australian Small Caps Closely

Simply Wall St.

Flight Centre Stock And 2 Founder Run ASX Shares Worth A Closer Look

Simply Wall St.

Mesoblast Achieves Patient Treatment Target in Phase 3 Trial of Chronic Lower Back Pain

MT Newswires Live

Mesoblast Achieves Target of 300 Treated Patients in Pivotal Phase 3 Trial for Chronic Low Back Pain

THOMSON REUTERS

ASX Stocks Estimated To Be Trading Below Fair Value In July 2026

Simply Wall St.

3 Australian Founder Led Stocks Backed By Strong Long Term Themes

Simply Wall St.

Stock Track | Mesoblast Soars 8.93% Intraday on Upbeat Ryoncil Cell Therapy Earnings

Australia's Mesoblast Extends Gains on Upbeat Ryoncil Cell Therapy Earnings

Founder Led Stocks With Real Skin In The Game

Simply Wall St.

Mesoblast (ASX:MSB) Is Up 8.7% After Strong Ryoncil Debut And FDA BLA Milestone - Has The Bull Case Changed?

Simply Wall St.

Why Retail Investors Are Tracking These 3 Australian Founder Led Stocks

Simply Wall St.

Australia's Mesoblast Hits over Two Week High on Upbeat Ryoncil Revenue

Stock Track | Mesoblast Soars 5% Intraday on Strong Ryoncil Revenue Results

Mesoblast Posts Ryoncil Q4 Net Revenue of $36M

Ryoncil® Delivers Net Revenue of Us$36m for the Fourth Quarter Ended 30 June 2026

THOMSON REUTERS

Press Release: Ryoncil(r) Delivers Net Revenue of Us$36m for the Fourth Quarter Ended 30 June 2026

Mesoblast Ltd - Ryoncil Q4 Net Revenue of Us$36m and Us$115m for Full Year

THOMSON REUTERS

3 Founder Led Australian Stocks Retail Investors Are Tracking Right Now

Simply Wall St.

3 Australian Founder Led Stocks With Long Term Skin In The Game

Simply Wall St.

Mesoblast Requests Modular Review of BLA for Rexlemestrocel-l in End-stage Heart Failure with LVAD

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/MSB.AU/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MSB.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"MSB.AU\",,,,,undefined,":{"symbol":"MSB.AU","market":"AU","secType":"STK","nameCN":"MESOBLAST LTD","latestPrice":2.36,"timestamp":1787292720000,"preClose":2.51,"halted":0,"volume":3452079,"delay":0,"changeRate":-0.05976095617529877,"nameEN":"MESOBLAST LTD","floatShares":786490638,"shares":1296862776,"eps":-0.10269059547566879,"marketStatus":"Not Yet Opened","change":-0.15,"latestTime":"08-21 16:12:00 AEST","open":2.48,"high":2.48,"low":2.34,"amount":8162983,"amplitude":0.055777,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.10269059547566879,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1787529600000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":2.51,"openAndCloseTimeList":[[1787270400000,1787292000000]],"volumeRatio":1.042834189266501,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"MSB.AU","preClose":2.51,"auctionPrice":2.36,"auctionVolume":425793,"auction":3,"marketStatus":"盘后竞价","timestamp":1787292600774}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"MSB.AU\",,,,,undefined,":{"symbol":"MSB.AU","floatShares":786490638,"roa":"-6.16%","roe":"-18.22%","lyrEps":-0.118019,"volumeRatio":1.042834189266501,"shares":1296862776,"dividePrice":0,"high":2.48,"amplitude":0.055777,"preClose":2.51,"low":2.34,"week52Low":1.88,"pbRate":"3.82","psRate":"33.54","week52High":3.31,"institutionHeld":0,"latestPrice":2.36,"eps":-0.10269059547566879,"divideRate":0,"volume":3452079,"delay":0,"ttmEps":-0.10269059547566879,"open":2.48,"prevYearClose":2.72,"prevWeekClose":2.36,"prevMonthClose":2.05,"prevQuarterClose":1.955,"fiveDayClose":2.21,"twentyDayClose":2.22,"sixtyDayClose":2.03,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MSB.AU\",params:#limit:5,,,undefined,":[{"date":"2025-02-26","symbol":"MSB.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740524400000,"name":null,"time":"","dateTimestamp":1740488400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MSB.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MSB.AU\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2651356415","title":"Founder Led Stocks For Investors Watching Australian Small Caps Closely","url":"https://stock-news.laohu8.com/highlight/detail?id=2651356415","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651356415?lang=en_us&edition=fundamental","pubTime":"2026-07-16 12:44","pubTimestamp":1784177081,"startTime":"0","endTime":"0","summary":"Founder led companies can look especially interesting when inflation, energy costs, and interest rate expectations are pulling markets in different directions. While global data points from US inflation readings to uneven growth in China and mixed signals in Europe keep broad indices on edge, founders often have a large personal stake in long term outcomes. The Founder-Led Companies screener focuses on leaders who built their business and still sit in the driver’s seat. In this article, you...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/4484222-main-header/1585186590706","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/4484222-main-header/1585186590706"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/consumer-services/asx-flt/flight-centre-travel-group-shares/news/founder-led-stocks-for-investors-watching-australian-small-c","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/consumer-services/asx-flt/flight-centre-travel-group-shares/news/founder-led-stocks-for-investors-watching-australian-small-c","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IISV.AU","XJO.AU","SLF.AU","VGFPF","STW.AU","QRE.AU","FEBU","BK7508","MAQ.AU","BK7501","GEAR.AU","BEAR.AU","BK4211","BK7070","DACE.AU","VOTE","DECU","EIGA.AU","BK7046","BK7043","IIGF.AU","IOZ.AU","VAS.AU","BK7042","FLT.AU","ISBC","OZR.AU","E200.AU","BK7067","ZYAU.AU","BK7511","MQG.AU","XKO.AU","VAP.AU","QFN.AU","BBOZ.AU","IMLC.AU","GIVE.AU","XAO.AU","OZF.AU","GXDW","MSB.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651051480","title":"Flight Centre Stock And 2 Founder Run ASX Shares Worth A Closer Look","url":"https://stock-news.laohu8.com/highlight/detail?id=2651051480","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651051480?lang=en_us&edition=fundamental","pubTime":"2026-07-15 08:32","pubTimestamp":1784075557,"startTime":"0","endTime":"0","summary":"When bond yields climb, inflation stays in focus and headlines are dominated by energy security and geopolitical risk, many investors look for leaders with real skin in the game. That is where founder led companies come in. This Founder-Led Companies screener focuses on businesses still guided by the people who built them and who remain personally invested in long term outcomes. This article highlights 3 stocks from the screener that stand out on qualitative grounds and provides a starting...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/4484222-main-header/1585186590706","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/4484222-main-header/1585186590706"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/consumer-services/asx-flt/flight-centre-travel-group-shares/news/flight-centre-stock-and-2-founder-run-asx-shares-worth-a-clo","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/consumer-services/asx-flt/flight-centre-travel-group-shares/news/flight-centre-stock-and-2-founder-run-asx-shares-worth-a-clo","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["MSB.AU","BK7070","BK7043","BK7501","FLT.AU","BK7508","MAQ.AU","BK7511","BK7067","BK7042","MQG.AU","BK7046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651128502","title":"Mesoblast Achieves Patient Treatment Target in Phase 3 Trial of Chronic Lower Back Pain","url":"https://stock-news.laohu8.com/highlight/detail?id=2651128502","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651128502?lang=en_us&edition=fundamental","pubTime":"2026-07-14 08:44","pubTimestamp":1783989850,"startTime":"0","endTime":"0","summary":"Mesoblast (ASX:MSB) achieved its target to treat at least 300 patients in a phase 3 trial of rexlemestrocel-L for chronic lower back pain linked to degenerative disc disease, according to a Tuesday fi","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","BK7501","MESO","BK4139","MSB.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651140024","title":"Mesoblast Achieves Target of 300 Treated Patients in Pivotal Phase 3 Trial for Chronic Low Back Pain","url":"https://stock-news.laohu8.com/highlight/detail?id=2651140024","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651140024?lang=en_us&edition=fundamental","pubTime":"2026-07-14 08:35","pubTimestamp":1783989339,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nTUA8RZFJG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","BK7501","BK7508","MSB.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651114411","title":"ASX Stocks Estimated To Be Trading Below Fair Value In July 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2651114411","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651114411?lang=en_us&edition=fundamental","pubTime":"2026-07-14 03:04","pubTimestamp":1783969477,"startTime":"0","endTime":"0","summary":"As tensions in the Middle East escalate, Australian markets are experiencing increased volatility, with energy stocks potentially rising due to climbing oil prices while other sectors may face downward pressure. In such uncertain times, identifying undervalued stocks can be a strategic approach for investors looking to capitalize on potential market inefficiencies and secure long-term value.","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/asx-stocks-estimated-to-be-trading-below-fair-value-in-july-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/asx-stocks-estimated-to-be-trading-below-fair-value-in-july-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7067","BK7153","KGN.AU","FDV.AU","NWH.AU","BBT.AU","BK7062","EOS.AU","BK7016","BK7115","BK7508","MSB.AU","SPHQ","LNW.AU","BK4585","PNV.AU","BK7015","NGI.AU","BK7078","BK7049","BK4588","LYL.AU","BK7126","SKS.AU","BK7002","BK7055","BK7501","BK7023","BK7503","XRO.AU","SLC.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651922061","title":"3 Australian Founder Led Stocks Backed By Strong Long Term Themes","url":"https://stock-news.laohu8.com/highlight/detail?id=2651922061","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651922061?lang=en_us&edition=fundamental","pubTime":"2026-07-13 14:23","pubTimestamp":1783923807,"startTime":"0","endTime":"0","summary":"Founder-led companies sit at an interesting crossroads of today’s markets, where inflation trends, energy costs, and shifting rate expectations regularly reshape sentiment. When a founder still calls the shots, incentives are closely tied to long-term outcomes, which can appeal to investors who want leaders personally committed to the business. This Founder Led Companies screener is designed to highlight stocks where that alignment is clear, regardless of sector. In this article, you will see...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/4484222-main-header/1585186590706","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/4484222-main-header/1585186590706"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/consumer-services/asx-flt/flight-centre-travel-group-shares/news/3-australian-founder-led-stocks-backed-by-strong-long-term-t","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/consumer-services/asx-flt/flight-centre-travel-group-shares/news/3-australian-founder-led-stocks-backed-by-strong-long-term-t","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["GEAR.AU","OZF.AU","BK7501","BK7508","XAO.AU","MQG.AU","BK7511","VAP.AU","ZYAU.AU","BK7067","FLT.AU","MSB.AU","IIGF.AU","BBOZ.AU","E200.AU","VAS.AU","BEAR.AU","XJO.AU","BK7042","AIPO","DACE.AU","QFN.AU","OZR.AU","QRE.AU","BK7043","EIGA.AU","BK7046","STW.AU","XKO.AU","GIVE.AU","SLF.AU","IMLC.AU","MAQ.AU","IISV.AU","BK7070","IOZ.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122101526","title":"Stock Track | Mesoblast Soars 8.93% Intraday on Upbeat Ryoncil Cell Therapy Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=1122101526","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122101526?lang=en_us&edition=fundamental","pubTime":"2026-07-13 08:50","pubTimestamp":1783903829,"startTime":"0","endTime":"0","summary":"Shares of Mesoblast Ltd (MSB.AU) are soaring, with the stock rising 8.93% during the intraday trading session.The significant price jump follows the company's announcement on Friday that its cell...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["MSB.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651643611","title":"Australia's Mesoblast Extends Gains on Upbeat Ryoncil Cell Therapy Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2651643611","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651643611?lang=en_us&edition=fundamental","pubTime":"2026-07-13 08:47","pubTimestamp":1783903622,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Mesoblast extends gains on upbeat Ryoncil cell therapy earnings** Shares of MesoblastMSB.AXextend gains, rising as much as 9.4% to A$2.45, their highest level since February 27** Stoc","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nL4N43F00V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","MSB.AU","BK7067","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650415750","title":"Founder Led Stocks With Real Skin In The Game","url":"https://stock-news.laohu8.com/highlight/detail?id=2650415750","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650415750?lang=en_us&edition=fundamental","pubTime":"2026-07-12 08:32","pubTimestamp":1783816325,"startTime":"0","endTime":"0","summary":"Founder led companies can offer something many investors value: clear alignment between leadership decisions and long term shareholder interests. With bond yields, inflation readings and energy prices all pulling markets in different directions, some investors are looking for leaders who are deeply tied to the long term outcome of their business, not just the next quarter. This Founder Led Companies screener focuses on stocks where decision makers have a personal legacy on the line. In this...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/4484222-main-header/1585186590706","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/4484222-main-header/1585186590706"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/consumer-services/asx-flt/flight-centre-travel-group-shares/news/founder-led-stocks-with-real-skin-in-the-game","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/consumer-services/asx-flt/flight-centre-travel-group-shares/news/founder-led-stocks-with-real-skin-in-the-game","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["FLT.AU","BK7043","BK7070","BK7508","BK7046","BK7067","BK7511","MQG.AU","BK7042","MSB.AU","BK7501","MAQ.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650157507","title":"Mesoblast (ASX:MSB) Is Up 8.7% After Strong Ryoncil Debut And FDA BLA Milestone - Has The Bull Case Changed?","url":"https://stock-news.laohu8.com/highlight/detail?id=2650157507","media":"Simply Wall St.","labels":["productRelease","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650157507?lang=en_us&edition=fundamental","pubTime":"2026-07-12 08:28","pubTimestamp":1783816116,"startTime":"0","endTime":"0","summary":"In July 2026, Mesoblast reported that the FDA had accepted its Biologics License Application for rexlemestrocel‑L in preventing life‑threatening gastrointestinal bleeding in end‑stage heart failure patients with LVADs, while the therapy continued to benefit from Orphan Drug and RMAT designations under newly clarified, more flexible FDA guidance for rare diseases.\nSeparately, Mesoblast disclosed record Ryoncil net revenue of US$36,000,000 for the quarter and US$115,000,000 for its first full...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/mesoblast-asxmsb-is-up-87-after-strong-ryoncil-debut-and-fda","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/mesoblast-asxmsb-is-up-87-after-strong-ryoncil-debut-and-fda","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["MSB","BK4585","BK7508","BK4006","MSB.AU","BK7501","LABU","BK4588","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650131698","title":"Why Retail Investors Are Tracking These 3 Australian Founder Led Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2650131698","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650131698?lang=en_us&edition=fundamental","pubTime":"2026-07-10 23:45","pubTimestamp":1783698305,"startTime":"0","endTime":"0","summary":"With inflation, energy prices and central bank moves all pulling markets in different directions, many investors are looking for leaders whose interests are closely aligned with their own. Founder led companies often fit that profile, with executives who have personal capital, reputation and long term legacy tied to each decision. Our Founder Led Companies screener is designed to spotlight these businesses so you can focus on leadership quality while the macro data shifts around rates, trade...","market":"hk","thumbnail":"https://images.simplywall.st/asset/company-cover/4484222-main-header/1585186590706","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/4484222-main-header/1585186590706"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/consumer-services/asx-flt/flight-centre-travel-group-shares/news/why-retail-investors-are-tracking-these-3-australian-founder","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/consumer-services/asx-flt/flight-centre-travel-group-shares/news/why-retail-investors-are-tracking-these-3-australian-founder","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7042","MSB.AU","VAP.AU","BK7501","MAQ.AU","OZR.AU","ZYAU.AU","BK7043","OZF.AU","BK4211","ISBC","EIGA.AU","BBOZ.AU","IMLC.AU","MQG.AU","IIGF.AU","BEAR.AU","BK7508","E200.AU","BK7070","BK7511","BK7067","GEAR.AU","XKO.AU","QFN.AU","STW.AU","IISV.AU","DACE.AU","FLT.AU","XJO.AU","BK7046","SLF.AU","XAO.AU","VAS.AU","QRE.AU","GIVE.AU","IOZ.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650390190","title":"Australia's Mesoblast Hits over Two Week High on Upbeat Ryoncil Revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=2650390190","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650390190?lang=en_us&edition=fundamental","pubTime":"2026-07-10 12:50","pubTimestamp":1783659050,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Mesoblast hits over two week high on upbeat Ryoncil revenue** Shares of MesoblastMSB.AXrise 7.9% to A$2.265, their highest level since June 24** On track for best day since April 15 i","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260710:nL4N43C0A9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","BK7508","MSB.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128639414","title":"Stock Track | Mesoblast Soars 5% Intraday on Strong Ryoncil Revenue Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1128639414","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128639414?lang=en_us&edition=fundamental","pubTime":"2026-07-10 11:14","pubTimestamp":1783653296,"startTime":"0","endTime":"0","summary":"Mesoblast Ltd's stock soared 5.00% during intraday trading on FRIDAY, following the release of its quarterly financial results.The biotech company announced that its Ryoncil product delivered net...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["MSB.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650903463","title":"Mesoblast Posts Ryoncil Q4 Net Revenue of $36M","url":"https://stock-news.laohu8.com/highlight/detail?id=2650903463","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650903463?lang=en_us&edition=fundamental","pubTime":"2026-07-10 09:27","pubTimestamp":1783646852,"startTime":"0","endTime":"0","summary":"July 10 (Reuters) - Mesoblast Ltd::*RYONCIL Q4 NET REVENUE OF US$36M AND US$115M FOR FULL YEAR*Further company coverage: MSB.AX* ((Reuters.Briefs@thomsonreuters.com;))((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))Source Date/Time = 09-JUL-202622:45:23.123 GMT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260710:nRSD2z4bWQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","BK7501","BK7508","MSB.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650138908","title":"Ryoncil® Delivers Net Revenue of Us$36m for the Fourth Quarter Ended 30 June 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2650138908","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650138908?lang=en_us&edition=fundamental","pubTime":"2026-07-10 08:30","pubTimestamp":1783643405,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260710:nTUA369W1M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","MSB.AU","BK7508","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650390813","title":"Press Release: Ryoncil(r) Delivers Net Revenue of Us$36m for the Fourth Quarter Ended 30 June 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2650390813","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650390813?lang=en_us&edition=fundamental","pubTime":"2026-07-10 08:30","pubTimestamp":1783643400,"startTime":"0","endTime":"0","summary":"NEW YORK, July 09, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced Ryoncil(R) (remestemcel-","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","BK4232","BK4006","BK4150","BK4139","BK4575","BK7067","MESO","R","MSC","MSB","BK7508","MSB.AU","BK4022"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650970174","title":"Mesoblast Ltd - Ryoncil Q4 Net Revenue of Us$36m and Us$115m for Full Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2650970174","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650970174?lang=en_us&edition=fundamental","pubTime":"2026-07-10 07:58","pubTimestamp":1783641511,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260709:nFWN43B17F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MSB.AU","BK7508","BK7501","MESO","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650945914","title":"3 Founder Led Australian Stocks Retail Investors Are Tracking Right Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2650945914","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650945914?lang=en_us&edition=fundamental","pubTime":"2026-07-09 10:33","pubTimestamp":1783564382,"startTime":"0","endTime":"0","summary":"With inflation worries, oil shocks and shifting interest rate expectations back in focus, many investors are looking for leaders who are personally invested in how their companies perform. Founder led stocks can offer exactly that, with management teams whose own legacies and wealth are closely tied to long term results. The Founder-Led Companies screener is designed to surface these businesses so you are not just backing an idea; you are backing the people behind it. Below, the article will...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/4484222-main-header/1585186590706","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/4484222-main-header/1585186590706"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/consumer-services/asx-flt/flight-centre-travel-group-shares/news/3-founder-led-australian-stocks-retail-investors-are-trackin-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/consumer-services/asx-flt/flight-centre-travel-group-shares/news/3-founder-led-australian-stocks-retail-investors-are-trackin-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7043","BK7067","IMLC.AU","BK4211","QFN.AU","IIGF.AU","E200.AU","DACE.AU","ISBC","BK7046","BK7511","GIVE.AU","XJO.AU","VAP.AU","VAS.AU","BBOZ.AU","BK7070","XKO.AU","MQG.AU","BK7042","IOZ.AU","QRE.AU","GEAR.AU","IISV.AU","MSB.AU","XAO.AU","FLT.AU","OZF.AU","MAQ.AU","EIGA.AU","OZR.AU","BK7501","BEAR.AU","BK7508","SLF.AU","STW.AU","ZYAU.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649987762","title":"3 Australian Founder Led Stocks With Long Term Skin In The Game","url":"https://stock-news.laohu8.com/highlight/detail?id=2649987762","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649987762?lang=en_us&edition=fundamental","pubTime":"2026-07-07 17:29","pubTimestamp":1783416553,"startTime":"0","endTime":"0","summary":"With inflation risks tied to oil supply tensions, shifting rate expectations in the UK and mixed signals from central banks worldwide, many investors are looking for company level resilience rather than macro calls. Founder led businesses can offer that, as leaders with large personal stakes often think in terms of decades, not quarters. This Founder Led Companies screener focuses on those entrepreneurs and original builders who are still at the helm and deeply invested in outcomes. In this...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/4484222-main-header/1585186590706","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/4484222-main-header/1585186590706"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/consumer-services/asx-flt/flight-centre-travel-group-shares/news/3-australian-founder-led-stocks-with-long-term-skin-in-the-g","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/consumer-services/asx-flt/flight-centre-travel-group-shares/news/3-australian-founder-led-stocks-with-long-term-skin-in-the-g","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7043","BK7508","GIVE.AU","IOZ.AU","BEAR.AU","BK7501","FLT.AU","XJO.AU","AIPO","BK7070","QRE.AU","XKO.AU","BK7067","SLF.AU","BBOZ.AU","E200.AU","VAS.AU","IMLC.AU","BK7042","GEAR.AU","VAP.AU","STW.AU","OZF.AU","IISV.AU","EIGA.AU","BK7046","XAO.AU","MQG.AU","OZR.AU","IIGF.AU","QFN.AU","DACE.AU","MSB.AU","BK7511","ZYAU.AU","MAQ.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649864106","title":"Mesoblast Requests Modular Review of BLA for Rexlemestrocel-l in End-stage Heart Failure with LVAD","url":"https://stock-news.laohu8.com/highlight/detail?id=2649864106","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649864106?lang=en_us&edition=fundamental","pubTime":"2026-07-06 15:45","pubTimestamp":1783323913,"startTime":"0","endTime":"0","summary":"July 1 (Reuters) - Mesoblast Ltd::*REQUESTS MODULAR REVIEW OF BLA FOR REXLEMESTROCEL-L IN END-STAGE HEART FAILURE WITH LVAD*REXLEMESTROCEL-L RECEIVES ORPHAN DRUG AND RMAT DESIGNATIONS*Further company ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nRSD6tn3Cb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MSB.AU","BK7067","BK7508","BK7501"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":4,"totalSize":176,"code":"91000000","status":"200"}]}}